Federal Court Blocks Edwards Lifesciences Medical Device Acquisition
The U.S. District Court for the District of Columbia granted the Federal Trade Commission's preliminary injunction request on Jan. 9, blocking Edwards Lifesciences' proposed $945 million acquisition of JenaValve Technology. The FTC argued the deal would reduce competition in the market for transcatheter aortic valve replacement devices that treat life-threatening heart conditions.